Hemi-ECMO: A Novel Method of Left Ventricular Afterload Reduction for Venoarterial Extracorporeal Membrane Oxygenation (VA-ECMO)
Bioengineering · 24.04.2026 · 13 (5) · 499
DOI: 10.3390/bioengineering13050499 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioengineering, online erschienen am 24.04.2026. Verfasst von Christian Said und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, The University of New South Wales, Kensington 2052, Australia. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) has failed to demonstrate mortality benefit in randomised controlled trials of cardiogenic shock. We aimed to determine whether a novel ‘Hemi-ECMO’ configuration, involving aortic occlusion to isolate the left ventricle from the VA-ECMO circuit, improves cardiac haemodynamics. We utilised a pulsatile biventricular mock circulatory loop with variable contractility to compare standard VA-ECMO with Hemi-ECMO support under left ventricular or biventricular failure conditions. When averaged across all pump speeds, mean left atrial pressure was significantly reduced with Hemi-ECMO compared to VA-ECMO (21.11 ± 1.32 mmHg vs. 26.53 ± 0.87 mmHg, p < 0.001), with more pronounced benefit at higher pump speeds. Aortic ejection increased with Hemi-ECMO at higher pump speeds: 0.14 ± 0.03 vs. 0.00 ± 0.00 L/min (p = 0.002) at 3000 revolutions per minute (RPM). Aortic ejection was greater with Hemi-ECMO in the descending aorta compared to the ascending aorta position (0.27 ± 0.03 L/min vs. 0.17 ± 0.05 L/min, p = 0.015). In conclusion, Hemi-ECMO demonstrates significant haemodynamic advantages in severe cardiogenic shock, including reductions in mean left atrial pressure and increases in aortic ejection, with greater benefits when positioned in the descending aorta. Further in vivo studies are warranted to assess clinical viability.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, The University of New South Wales, Kensington 2052, Australia.
- The Victor Chang Cardiac Research Institute, Darlinghurst 2010, Australia.
- Department of Cardiology, St Vincent's Hospital, Darlinghurst 2010, Australia.
- Department of Cardiology, Royal Prince Alfred Hospital, Camperdown 2050, Australia.
- School of Medicine, The University of Sydney, Camperdown 2050, Australia.
ORCID-Profile: Christian Said, Christopher Hayward, Michael Stevens, Laurence Boss, Pankaj Jain
Zitieren
APA
Said, C., Hayward, C., Stevens, M., Vazquez, G. M., Boss, L., Deveza, R., Barua, S., Muthiah, K., & Jain, P. (2026). Hemi-ECMO: A Novel Method of Left Ventricular Afterload Reduction for Venoarterial Extracorporeal Membrane Oxygenation (VA-ECMO). Bioengineering, 13(5), 499. https://doi.org/10.3390/bioengineering13050499
Vancouver
Said C, Hayward C, Stevens M, Vazquez GM, Boss L, Deveza R, et al. Hemi-ECMO: A Novel Method of Left Ventricular Afterload Reduction for Venoarterial Extracorporeal Membrane Oxygenation (VA-ECMO). Bioengineering. 2026;13(5):499. doi:10.3390/bioengineering13050499
BibTeX
@article{Said2026,
author = {Said, Christian and Hayward, Christopher and Stevens, Michael and Vazquez, Gabriel Matus and Boss, Laurence and Deveza, Ricardo and Barua, Sumita and Muthiah, Kavitha and Jain, Pankaj},
title = {Hemi-ECMO: A Novel Method of Left Ventricular Afterload Reduction for Venoarterial Extracorporeal Membrane Oxygenation (VA-ECMO)},
journal = {Bioengineering},
year = {2026},
volume = {13},
number = {5},
pages = {499},
doi = {10.3390/bioengineering13050499}
}
EUVIMED